Introduction
Chronic myeloid leukaemia (CML) is a clonal disorder of pluripotent hematopoietic cells characterized by the presence of the Philadelphia chromosome (Ph + ) and hence the chimeric protein Bcr ± Abl (for reviews see Sawyers, 1993; Gotoh and Broxmeyer, 1997) . Bcr ± Abl is a constitutively activated form of the Abl protein tyrosine kinase (PTK) (Konopka et al., 1984; Lugo et al., 1990) . Numerous in vivo studies have demonstrated that Bcr ± Abl has an essential role in the molecular pathology of Ph + leukaemias (Daley et al., 1990; Griths et al., 1992; Heisterkamp et al., 1990; Honda et al., 1995; Kelliher et al., 1990) . CML is a progressive disease with an initial chronic phase followed by a more aggressive blast crisis (reviewed by Clarkson and Strife, 1993; Verfaille, 1998) .
CML progenitor cells possess only a subtle defect in maturation, whilst retaining their requirements for bone marrow stromal cells or cytokines to survive and proliferate (Gishizky and Witte, 1992; Wang, 1992) . Recent data does, however, suggest that some CML progenitors can undergo autocrine proliferation (Jiang et al., 1999) . The relative response to some cytokines, compared to normal progenitor cells, may also be altered in CML. Stem Cell Factor (SCF) is a cytokine that is produced in the bone marrow and is essential for normal hematopoiesis (reviewed by Galli et al., 1994) . SCF combines synergistically with other cytokines to promote the growth of primitive hematopoietic cells and it can also stimulate the formation of mature neutrophilic cells from committed myeloid progenitor cells.
The response of progenitor cells to SCF is altered in CML: CML progenitors are more responsive to SCF as a single cytokine, than normal progenitors (Moore et al., 1998) ; they engraft more eectively into NOD ± SCID mice after injection of SCF (Lewis et al., 1998) ; SCF de®cient stroma favours normal progenitor cell growth compared to CML progenitor growth (Agarwal et al., 1995) . These dierences may be a consequence of the proposed ability of BCR ± ABL PTK to interact with the SCF receptor, c-kit (Hallek et al., 1996) . There is as yet, however, no direct evidence of a Bcr ± Abl mediated potentiation of SCF responses in multipotent hematopoietic cells. To produce an experimentally relevant, convenient model of CML to investigate molecular mechanisms underlying the Bcr ± Abl mediated eects on primitive hematopoietic cells, we have expressed a conditional mutant of Bcr ± Abl in the primitive multipotent hematopoietic cell line, FDCP ± Mix (Pierce et al., 1998a (Pierce et al., , 2000 .
We have previously reported that expression of BCR ± ABL PTK for up to 3 weeks in the FDCP ± Mix cells does not alter their ability to dierentiate or their absolute requirement for growth factors to survive and proliferate (Pierce et al., 1998a) . However, in the absence of added growth factor the cells display increased survival and in sub-optimal concentrations of growth factor enhanced proliferation. In contrast, prolonged exposure to BCR ± ABL PTK activity (12 weeks or longer) results in the acquisition of BCR ± ABL dependent growth factor independence and a post-transcriptional reduction in the level of p53 which drives a delay in dierentiation in the FDCP ± Mix cells (Pierce et al., 2000) . We, therefore, have a model system in which to study the short term and long term consequences of Bcr ± Abl activity that mimics the chronic phase to accelerated phase transition of CML.
Here we report the eects of short term and prolonged exposure to BCR ± ABL PTK on c-kit expression and SCF-stimulated hematopoietic cell proliferation and dierentiation. We show a profound change in response to SCF, that explains some of the observed eects of Bcr ± Abl in CML patients. Our model has exposed the fact that STI571 can modulate proliferation and development via inhibition of both ckit and Bcr ± Abl in primitive hematopoietic cells.
Results

Exposure to BCR ± ABL activity elevates the mitogenic response to SCF
We have previously established a model system for the study of CML by expression of a temperature sensitive (ts) Bcr ± Abl protein tyrosine kinase in the multipotent hemopoietic cell line FDCP ± Mix (Pierce et al., 1998a (Pierce et al., , 2000 . The p210 tsBcr ± Abl cDNA encodes for a temperature sensitive mutant of p210 BCR ± ABL, expression is unaected by temperature but its tyrosine kinase activity is present at 328C (permissive temperature) and inactive at 398C (restrictive temperature). The tsBcr ± Abl FDCP ± Mix model exhibits many of the features of the chronic phase to accelerated phase transition of CML (Pierce et al., 2000) . There are distinct dierences between cells exposed to Bcr ± Abl PTK activity for short periods (de®ned here as less than 3 weeks and referred to as short-term (ST) 328C cells) and cells exposed for 12 weeks or more (referred to here as long-term (LT) 328C cells) (Pierce et al., 1998a (Pierce et al., , 2000 . As outlined in the introduction the dierences between LT328C and ST328C tsBcr ± abl FDCP ± Mix cells resemble the dierences seen between the chronic phase and accelerated phase of CML. Because of the inducible nature of the Bcr ± Abl PTK we have the opportunity to de®ne the short term and long term consequences of Bcr ± Abl PTK activity by comparing the LT328C and ST328C tsBcr ± abl FDCP ± Mix cells. The cell populations used in this study were: LT398C cells, cells maintained with Bcr ± Abl PTK inactive (growth factor dependent); ST328C cells, cells maintained with Bcr ± Abl PTK inactive before having Bcr ± Abl PTK activated for less than 10 days (i.e. LT398C assayed at 328C); LT328C cells, cells maintained with Bcr ± Abl PTK constantly active for 12 weeks or more (growth factor independent); LT 32/ 398C, cells maintained for 12 weeks or more with Bcr ± Abl activated before having Bcr ± Abl PTK activity removed by temperature switch (for at least 18 h).
The ability of Bcr ± Abl to alter the response to cytokines such as IL-3 (Pierce et al., 1998a (Pierce et al., , 2000 led us to investigate the response of the cells to other growth factors. Hallek et al. (1996) have shown that there is an interaction between the SCF receptor (cKit) and BCR ± ABL and that CML progenitor cells may have pre-activated c-Kit. For this reason we wished to examine the early and chronic eects of BCR ± ABL PTK on SCF responses in multipotent cells. In multipotent cell populations SCF often has little eect when added alone, this is also true in FDCP ± Mix cells (see Figure 1 and Heyworth et al., 1990) . However, the response to SCF when BCR ± ABL PTK was active in these cells was remarkably dierent (Figure 1 ). This was true both for LT328C cells (cells cultured at the permissive temperature for BCR ± ABL PTK in IL-3 for long term and had become growth factor independent (Pierce et al., 2000) ) and ST328C cells (cells cultured at the permissive temperature for BCR ± ABL PTK for short term which remain growth factor dependents, i.e. LT398C cells cultured at 328C for the assay period). There was a pronounced increase in ]thymidine incorporation assays following incubation at both 398C (Bcr ± Abl OFF) and 328C (Bcr ± Abl ON) for 18 h. Data are expressed as a percentage of thymidine incorporation observed at maximally stimulating concentration of IL-3 (with 10% HS). Results are the mean of at least three separate experiments and in no case was the standard error of the mean greater than 7%. Data was analysed in a student t-test, asterisks illustrate data points showing signi®cant dierence between Bcr ± Abl OFF and Bcr ± Abl ON, **P50.01; ***P50.005 dine incorporation the SCF response was further diminished, indicating that the eects of Bcr ± Abl on this response were only slowly reversible after weeks in the presence of BCR ± ABL PTK activity (results not shown). The SCF stimulated DNA synthesis was Bcr ± Abl mediated and not associated with temperature switch, because it was not seen at 328C in the parental FDCP ± Mix cells. The ST328C tsBcr ± Abl FDCP ± Mix cells (LT398C cells assayed at 328C) also exhibited increased SCF-stimulated proliferation at the permissive but not the restrictive temperature, indicating that the BCR ± ABL has an immediate eect on SCF response (Figure 1 ). The level of proliferative response seen in the LT328C tsBcr ± Abl FDCP ± Mix cells (cells exposed to BCR ± ABL kinase activity for weeks compared to days) however, was far more striking. As we have shown previously (Pierce et al., 1998a) , ST328C tsBcr ± Abl FDCP ± Mix cells have a similar response to GM ± CSF and still require IL-3 to proliferate. Thus, SCF responses are the major change seen in cytokine responses examined in FDCP ± Mix cells when BCR ± ABL PTK is active.
BCR ± ABL PTK increases the level of SCF receptor expression
A possible explanation for the BCR ± ABL stimulated increase in response to SCF in the LT328C and ST328C tsBcr ± Abl FDCP ± Mix cells is enhanced expression levels of the SCF receptor, c-kit. To investigate this we used¯ow cytometric analysis of c-kit cell surface expression in control FDCP ± Mix, ST328C (Table 1) and LT328C tsBcr ± Abl FDCP ± Mix cells ( Figure 2 and Table 1 ). The data from these experiments clearly indicate a Bcr ± Abl mediated increase in FDCP ± Mix c-kit expression. The increase in c-kit expression is reversible when BCR ± ABL PTK activity is removed either by temperature switch (in the case of LT328C tsBcr ± Abl cells) ( Figure 2a , Table 1 ) or addition of STI571 ( Figure 2b , Table 1 ). STI571 (Novartis Pharma AG, Basel, Switzerland) reduced the level of c-Kit expression in cells exposed either short term or long term to BCR ± ABL PTK (Table 1) . It is important to note that endogenous levels of c-kit expression in FDCP ± Mix cells were not reduced by STI571. Thus, at least part of the Bcr ± Abl enhanced response to SCF is likely to be due to increased cell surface receptor expression.
Semi-quantitative PCR analysis fails to show any increase in c-Kit mRNA levels as a consequence of Bcr ± Abl activity (Figure 3 ). This indicates that the increase in cell surface receptor expression occurs at the post-transcriptional level.
SCF plus G-SCF induced differentiation of FDCP ± Mix cells is delayed by BCR ± ABL PTK
The enhanced proliferative response to SCF in cells expressing active BCR ± ABL PTK is clear, but FDCP ± Mix cells also undergo dierentiation to The expression of c-Kit in LT328C tsBcr-Abl, ST328C tsBcr-Abl and parental FDCP-Mix cells was determined by¯ow cytometry. Cells were labelled with FITC conjugated anti-c-Kit antibody after pretreatment with or without 10 mM STI571. The results shown are the mean with s.e.m. of at least three expreiments neutrophils in the presence of SCF and low concentrations of IL-3 plus G-CSF (Heyworth et al., 1990) . We, therefore, analysed the dierentiation and maturation of LT398C and LT328C tsBcr ± Abl FDCP ± Mix, cultured at both the permissive and the restrictive temperatures ( Figure 4 ). There was on average an eightfold increase in cell number after 7 days in all conditions during the dierentiation assays.
The control FDCP ± Mix cells formed early granulocytic cells and then mature neutrophils over a 7 ± 10 day period (Figure 4a) . Following maturation the cells become postmitotic, and in the case of granulocytes, undergo apoptosis. The dierentiation and development of the FDCP ± Mix cells occurred at both 328C and 398C (Figure 4a ) and as previously reported (Pierce et al., 1998a) .
As previously reported, LT398C tsBcr ± Abl FDCP ± Mix cells cultured in a high concentration of IL-3 maintain a primitive cell morphology (Pierce et al., 2000) . When these cells were switched to conditions that induce myeloid dierentiation (low IL-3+SCF+G-CSF) at either the permissive or restrictive temperature (Figure 4b ), the cells underwent granulocytic development with the clonal extinction of colony forming cells. At day 14 no blast cells or cells capable of forming colonies in soft gel assays remained. Thus, after maintenance for prolonged periods in conditions that maintain the primitive cell phenotype, the LT398C tsBcr ± Abl FDCP ± Mix cells can response to induction of myeloid cell dierentiation in the absence (398C) or presence (328C) of active BCR ± ABL PTK (Figure 4b) . However, the rate at which dierentiation occurs is Prolonged exposure to active p210 BCR ± ABL PTK results in a delay of dierentiation in response to SCF plus G ± CSF. FDCP ± Mix control, LT328C and LT398C tsBcr ± Abl cells were plated in culture conditions which promote granulocytic development (low concentrations of IL-3, plus SCF and G-CSF) and incubated at 328C (Bcr ± Abl on) and 398C (Bcr ± Abl o). Cytospins were prepared on day 7 and stained with May ± Grunwald ± Giemsa. Dierential morphology was scored for greater than 100 cells per slide. These results are the mean of three experiments. The s.e.m. did not exceed 10% for any data points. (a) FDCP ± mix control assayed at 328C and 398C. (b) LT398C FDCP ± mix tsBcr ± Abl, assayed at 328C and 398C. (c) LT328C FDCP ± mix tsBcr ± Abl, assayed at 328C and 398C markedly delayed at the permissive temperature for BCR ± ABL PTK (328C). This was not due to increased apoptosis of committed progenitor cells in the presence of BCR ± ABL PTK. There were less than 5% apoptotic cells during early phases of the cultures and in later stages of the dierentiation assays the numbers of apoptotic cells was not signi®cantly dierent between cultures in the presence and absence of BCR ± ABL PTK activity. The delay in dierentiation is apparent following 7 days in culture (Figure 4b ) and persists after 10 days when still many more early granulocytic cells are present (68%+10), compared to those cultured at 398C (17%+3), or the control FDCP ± Mix cells dierentiated at 328C (11%+4). This was in contrast to experiments where the cells were induced to dierentiate using GM ± CSF, G-CSF and low concentrations of IL-3 where no signi®cant maturation delay was observed in the presence of the BCR ± ABL PTK (ST 328C cells) (Pierce et al., 1998a) . Thus BCR ± ABL PTK acutely and selectively potentiates the response to speci®c cytokines during dierentiation and development.
The LT328C tsBcr ± Abl FDCP ± Mix cells cultured in IL-3 also maintained a primitive cell morphology (Pierce et al., 2000) . When these cells were induced to undergo neutrophilic development (in low concentrations of IL-3 plus SCF+G ± CSF) at 398C (Figure 4c ) normal cell maturation was observed, with the formation of neutrophils at a rate that was comparable to that seen in control FDCP ± Mix cells (Figure 4a) .
However, when LT328C tsBcr ± Abl FDCP ± Mix cells were induced to undergo neutrophilic development at the permissive temperature there was evidence of a marked reduction in the rate of dierentiation ( Figure  4c ). After 7 days in culture, cells with an early granulocytic morphology were still dominant (73%+3). This is indicative of a developmental block or delay. Given the less marked eect of BCR ± ABL PTK on dierentiation of FDCP ± Mix in conditions which exclude SCF (low concentrations of IL-3 plus GM ± CSF and G ± CSF) (Pierce et al., 1998a (Pierce et al., , 2000 we conclude that this result is driven by the ability of BCR ± ABL to potentiate the cellular response to SCF. The developmental delay is not due to the factor independence of these cells for the following reasons. It was not observed when the cells were induced to dierentiate in the absence of SCF (low concentrations of IL-3 plus GM ± CSF and G ± CSF (Pierce et al., 2000) ) and was apparent, albeit to a lesser extent, in cells exposed to BCR ± ABL PTK only during the assay period (ST328C cells which are factor dependent) (Figure 4b ). The delay we observe however, is commensurate with the observations of Clarkson and Strife (1993) , on the retarded development rate of myeloid progenitors in CML.
STI571 can inhibit the expression of c-Kit and the proliferation of tsBcr ± Abl FDCP ± Mix cells, especially in the presence of SCF STI571 inhibits c-Kit as well as BCR ± ABL (Heinrich et al., 2000) . The data above suggest that one facet of STI571 activity may be to inhibit BCR ± ABL PTK activity and thereby reduce c-Kit mediated responses. This FDCP ± Mix model oers an opportunity to perform some molecular pharmacologic experiments that may shed light on this. We therefore checked the ability of STI571 to inhibit the expression of c-kit. Table 1 and Figure 2 demonstrate that there is clear inhibition by STI571 of the BCR ± ABL stimulated increase in c-Kit expression. Does this correlate with a decrease in BCR ± ABL-stimulated DNA synthesis in LT328C tsBcr ± Abl FDCP ± Mix cells and c-Kit plus BCR ± ABL stimulated DNA synthesis?
The data in Figure 5 show that this is the case. The BCR ± ABL-stimulated [ 3 H]thymidine incorporation in LT328C tsBcr ± Abl FDCP ± Mix was inhibited 55% by STI571. Furthermore, when SCF was also added to these cells the inhibition observed was increased to 71%. We interpret this as STI571 having several modes of action: inhibition of BCR ± ABL stimulated DNA synthesis; inhibition of c-Kit expression; inhibition of SCF signalling via direct inhibition of c-Kit PTK; inhibition of c-kit/BCR ± ABL interactions leading to synergistic eects on proliferation. Perhaps signi®cantly, the further addition of IL-3 to the cultures partially relieved the inhibitory eects of STI571 (54% inhibition in SCF+IL-3). Thus the eects of STI571 on BCR ± ABL and/or SCF mitogenic eects is diminished by another cytokine being present and the principle eect observed is on the BCR ± ABL stimulated STI571 can inhibit the proliferation and promote the differentiation of cells chronically exposed to BCR ± ABL PTK activity STI571 clearly inhibits the proliferation induced by the prolonged expression of BCR ± ABL PTK activity in FDCP ± Mix cells. BCR ± ABL also potentiates the SCF response in FDCP ± Mix, a response that can be coupled to cellular dierentiation. We assayed the eects of STI571 on LT328C tsBcr ± Abl FDCP ± Mix in the presence of SCF+G-CSF plus low concentrations of IL-3. The most profound eect observed in LT328C tsBcr ± Abl FDCP ± Mix cells was the decrease in cell number observed after 7 days (Table 2) . From this we conclude that the anti-proliferative action of STI571 has a major eect on developing FDCP ± Mix cells. In the cells remaining, in the presence of either 1 or 10 mM STI571, there was an increase in the percentage of neutrophils present that was related to the STI571 concentration (Table 2 ). Whilst it is dicult to entirely separate the antiproliferative eects of the drug from its ability to abrogate the delay in dierentiation imposed by BCR ± ABL, the data suggest that both eects are in¯uenced by the addition of STI571.
Discussion
The Ph + stem and progenitor cell populations in CML express BCR ± ABL, and have been documented as having only subtly dierent characteristics from normal cells using a number of dierent in vitro assays. These include disregulation of cell cycling, adhesion, homing or chemotaxis, self-renewal and response to hematopoietic cell growth inhibitory chemokines (reviewed by Eaves et al., 1998) . In vivo studies con®rm the pivotal role of Bcr ± Abl in CML but the direct cause to eect linkage between the cellular characteristics of CML cells and Bcr ± Abl needs further description. Recent successes with retroviral mediated gene transfer of Bcr ± Abl into CD34 progenitors have allowed the direct consequences of BCR ± ABL PTK on some facets of cell behaviour to be documented. The application of the speci®c BCR ± ABL PTK inhibitor STI571 to the study of CML progenitor cells will allow de®nition of molecular and cell biological consequences of BCR ± ABL action.
To understand BCR ± ABL action on hematopoietic stem cells we have used the multipotent cell line FDCP ± Mix. This cell line has been shown to be of value in discerning the functional role of retinoic acids (Tsai et al., 1992) , structure/function characteristics of receptors (Evans et al., 1999) and the role of mutant Ras (Darley and Burnett, 1999) in multipotent cells. We have, therefore, examined the eects of BCR ± ABL PTK on these cells using a temperature sensitive mutant. The eects of Bcr ± Abl were similar to that seen in CML progenitors: the cells remained growth factor dependent and could undergo dierentiation in a combination of IL-3, G ± CSF and GM ± CSF (Pierce et al., 1998a) . However following prolonged exposure to BCR ± ABL PTK activity the cells become growth factor independent for survival and display a reduced level of p53 which drives a delay in dierentiation (Pierce et al., 2000) .
Here, we report that Bcr ± Abl markedly aects the response of the FDCP ± Mix cells to SCF. In the presence of Bcr ± Abl they display an increased mitogenic response to SCF and a pronounced delay in dierentiation. These eects are in part due to an increase in the cell surface expression of the SCF receptor c-Kit. It is important to emphasise that previous data have indicated a common set of substrates for c-Kit and BCR ± ABL PTK suggesting either a Bcr ± Abl mediated activation of c-Kit in the absence of ligand, or common activation of signalling cascades. Further, c-Kit and BCR ± ABL may be associated in whole cells (Hallek et al., 1996; Wisniewski et al., 1996) . Thus, common BCR ± ABL and c-Kit mediated signal transduction events, or indeed functional stabilization of the active conformation of the c-Kit protein by BCR ± ABL may also be underlying this cell biological eect. The Bcr ± Abl induced increase in c-kit expression is reversible by both temperature switch and the addition of STI571. STI571 has been reported to inhibit c-kit signalling (Heinrich et al., 2000) without having an eect on expression levels. It is important to point out that our ®ndings are not in con¯ict with these results as the addition of STI571, whilst abrogating the Bcr ± Abl induced increase in c-Kit expression does not reduce its level below normal endogenous levels. This observation that Bcr ± Abl can change protein expression without altering RNA expression levels has been reported previously (Dai et al., 1998; Pierce et al., 2000) .
These ®ndings from the FDCP ± Mix model have clinical relevance in that the CML progenitor cell has a compromised or altered response to SCF. There is a molecular association of c-Kit and BCR ± ABL (Hallek et al., 1996) and similar tyrosine phosphorylation events are stimulated by these two tyrosine kinases (Carpino et al., 1997; Wisniewski et al., 1996) . Furthermore, CML cells grown on immortalized foetal liver stromal cells from homozygous SCF-de®cient LT328C tsBcr-Abl FDCP-Mix cells were washed twice and resuspended in IL-3 (0.1 ng/ml), SCF (150 ng/ml) and G-CSF (3000 U/ml) in the presence and absence of STI571 (1 or 10 mM) at 328C. The fold increase in cell number and the morphology of the cells was determined after 7 days. Results are the mean+s.e.m. of at least three experiments mice cannot produce Ph + clonogenic cells at the same rate as when soluble SCF is present, or the stromal cells were engineered to express transmembrane SCF (Agarwal et al., 1995) . SCF may, therefore, favour the malignant progenitors as in the absence of SCF the normal (Ph negative) cells had a growth advantage. We have now presented evidence that this is a direct consequence of BCR ± ABL PTK action on progenitor cells. SCF as the sole growth factor present also promotes Ph + CD34 + , CD38 + or CD34 + , CD38 -single cell growth far more eectively than is seen in their normal counterparts (Moore et al., 1998) . Elegant co-culture experiments demonstrate that this is not due to autocrine or paracrine release of cytokines. In other words, it is as a direct consequence of intracellular eects of BCR ± ABL PTK on c-Kit signalling and, as a consequence, a greater number of GM ± CFC are formed. The morphologic and phenotypic analysis of the SCF treated CD34 CML cells showed a primitive appearance without major increases in the expression of mature cell surface markers in contrast to their normal counterparts. Our data from tsBcr ± Abl FDCP ± Mix cells support the hypothesis that such delays in dierentiation are as a direct consequence of BCR ± ABL action on the cellular response to SCF. This has important consequences for our understanding of CML. The ability of BCR ± ABL to speci®cally and markedly subvert the c-Kit signal transduction pathway potentially oers new means of treating this disease. Con®rmation of the direct action of BCR ± ABL in potentiating this response con®rms the use of c-Kit as a potential drug target. The fascinating aspect to this is, however, the fact that direct inhibition of BCR ± ABL and direct or indirect inhibition of c-Kit are achieved with the use of the drug STI571. The potential advantage in terms of growth and engraftment (Lewis et al., 1998; Moore et al., 1998) oered to CML progenitors by Kit activation can be overcome by STI571 inhibition of the c-Kit kinase. At lower doses of STI571, BCR ± ABL PTK (which we have shown is the direct causative agent of the enhanced SCF response) will be inhibited and thereby the enhanced response to SCF will still be abrogated. This double-edged sword may, potentially, be one reason for the speci®city and eectiveness of STI571 against the Ph + progenitor cells.
Materials and methods
Maintenance and transfection of FDCP ± Mix cells FDCP ± Mix p210 tsBcr ± Abl cells were produced as previously described in (Pierce et al., 1998a (Pierce et al., , 2000 . The p210 tsBcr ± Abl cDNA encodes for a temperature sensitive kinase mutant of p210 BCR ± ABL. Expression is unaected by temperature but its tyrosine kinase activity is present at 328C (permissive) and inactive at 398C (restrictive temperature).
Conditions for inducing myeloid differentiation in the FDCP ± Mix cells FDCP ± Mix A4 cells were washed twice in Fischers medium (800 g, 10 min) and resuspended at 6610 4 cells/ml in Iscoves Modi®ed Dulbeccos Medium supplemented with foetal calf serum (20% v/v), and r-human G ± CSF (3000 U/ml, Amgen, Thousand Oaks, CA, USA) and r-murine IL-3 (0.1 ng/ml, Calbiochem, Nottingham, UK) and recombinant rat SCF (150 ng/ml, Amgen, Thousand Oaks, CA, USA). They were cultured in an atmosphere of 5% CO 2 in air. Cytospins were prepared using a Shandon cytospin 2 (55610 4 cells/slide at 1000 r.p.m. for 5 min). Cytospin preparations were stained with May ± Grunwald ± Giemsa and dierential morphology scored for greater than 100 cells per slide.
Measurement of DNA synthesis
DNA synthesis was measured using a [ 3 H]thymidine incorporation assay as previously described (Pierce et al., 1998b) .
Flow cytometry
Flow cytometric analysis was performed using a Becton Dickinson FacsVantage instrument. Cells expressing c-Kit were identi®ed using a c-Kit antibody directly conjugated tō uorescein isothiocyanate (FITC) (Pharmingen, San Diego, CA, USA).
RT ± PCR
Poly(A) + PCR material was prepared as described in (AlTaher et al., 2000) . Poly(A) + cDNA samples were used to amplify cKit speci®c genes using the following cycle pro®le: 30 cycles consisting of 948C for 30 s, 548C for 30 s and 688C for 1 min. All primers were designed within 250 bp of the poly(A) + tail. The cKit primers were; forward primer ctttcagttgcttgatgtttgg, reverse primer cttcagaactgtcaacagttgga giving a 222 bp fragment. PCR products were detected by agarose gel electrophoresis. Genomic DNA as used as positive controls. PCR was also undertaken on a dilution series of the cDNAs used to con®rm the semi-quantitative nature of the PCR.
